BlackBerry's rally hits the wall after disappointing Q1 >>> READ MORE

NVO

Recent Articles

5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio

VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies. Here's why VVUS stock is a must More 

Global Blood Therapeutics Inc (GBT) Stock Soars on Takeover Talk

Global Blood Therapeutics (GBT) stock is rising as the company is being targeted for a takeover by another pharma corporation. Here's what's happenig More 

9 Top Pharmaceutical Stocks to Buy for the Dividends

Fans of dividends don't have to completely abandon all hope for growth too -- these top pharmaceutical stocks offer the best of both worlds. More 

3 European Stocks to Buy for Big-Time Dividends

Don't overlook European stocks when it comes to dividends. Companies like Diageo (DEO), Novo Nordisk (NVO) and Eni (E) are stellar. More 

3 Big Pharma Stocks Under Pressure From Washington

We cover the technical condition of three Big Pharma stocks, with the help of Profit Scanner, to determine where their prices may be headed. More 

7 Healthcare Stocks That Are Investor Poison

You can't blindly buy stocks in healthcare because there are some that have some serious problems. More 

5 Pharmaceuticals Stocks to Sell Now

The ratings of 5 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More